Humanized
Navigation Links
Humanized in Medical News
PDL BioPharma Elects Barry Selick to Its Board of Directors
...of the technology underlying the creation of fully humanized antibody therapeutics and applied this technology ...company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in...PDL BioPharma Announces Second Quarter 2009 Financial Results
... and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more info...Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog...Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog...... and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more info...
UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog whi...Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog whi...Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog whi...Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog......delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; and Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which...
Humanized in Medical Technology
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog......livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog...
...About Teplizumab Teplizumab, an investigational compound under development for the treatment of individuals with recent-onset type 1 diabetes, is a humanized monoclonal antibody engineered to alter the function of the T lymphocytes that mediate the destruction of the insulin-producing beta cells of the isle...
...occurring in the AMBITION study were infections and gastrointestinal disorders. About ACTEMRA (R) (tocilizumab) ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody being studied for the treatment of RA. Studies demonstrate that reducing the activity of ...
Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
...delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; and Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which......ost frequently in the ACTEMRA arms of the LITHE study were serious infections. About ACTEMRA (R) (tocilizumab) ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody being studied for the treatment of RA. Studies demonstrate that reducing the activity of ...
Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
...tion of a second Phase I human safety trial of Anthim(TM), a high-affinity humanized and deimmunized monoclonal antibody targeting the anthrax toxin protective ...apy even more acute. Anthim Background Anthim is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of ......ess model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization. Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is signifi...
...ted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in ...
...er's disease and other disorders. The Company's drug product pipeline includes OXIGON(TM), which has been tested in Phase 1 clinical trials; IN-N01, a humanized monoclonal antibody designed to promote the clearance of soluble beta amyloid; and RECALL-VAX, a vaccine technology that has potential to delay or pre...
Humanized in Biological News
Mouse model provides clues to human language development
...ters, including the ability to see and hear, bone density, important metabolic functions and a number of neurological functions. The mice carrying the humanized Foxp2 gene showed no physiological abnormalities. However, behavioral tests showed an altered exploratory behavior and reduced movement activity both...UC Davis researchers exploring gene therapy to fight AIDS
...an now move forward and test the safety of the viral vectors, as well as the ability of anti-HIV genes to inhibit HIV infection," noted Anderson. "The humanized mouse model is an important step toward bringing this possible cure to patients." Bauer and Anderson are hoping to demonstrate in their mouse model...Anything but modest: The mouse continues to contribute to humankind
...searchers discuss how mice help us understand disease, but they also highlight methods which enable research of novel disease therapies. For example, humanized mice mice engineered to carry human genes can provide new experimental systems for testing new therapeutics. ...Is hybridoma production about to take a quantum leap forward?
... The most obvious advantage would be to bypass the interference from the patient's immune system that typically characterizes the use of chemerical or humanized antibodies. Due to the growing interest and the potential benefits, the efficient production of human monoclonal antibodies is a high priority. But a......ormal amount of protein, than patients receiving paclitaxel alone. Other side effects were similar between the two treatment groups. Bevacizumab, a humanized monoclonal antibody** that already has been approved for metastatic colorectal cancer in combination with chemotherapy, is designed to bind to and inh...
Inexpensive, mass-produced genes core of synthetic biology advances at UH
...ents, including vaccines for HIV and other viral diseases. This technology also will facilitate development of new medications through the creation of humanized yet synthetic antibodies that could be especially useful in detection and treatment of infectious organisms that could be used by terrorists. ...Humanized in Biological Technology
New Vitality hrGFP expression vectors
for monitoring gene expression and localizing proteins in vivo
New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence
Humanized Renilla GFP Reporter
...
...iation of the PARADIGM trial, a Phase 2 clinical study evaluating MGAWN1, a humanized monoclonal antibody, for the treatment of individuals with suspected centra... advancement for these patients." About MGAWN1 MGAWN1 is a humanized monoclonal antibody that specifically recognizes the envelope (E) protein o...
... affinity and/or titer, for therapeutic applications and high-titer manufacturing cell lines. The company has assembled a portfolio of lead human and humanized antibodies to antigens associated with cancer, neovascular, inflammatory and infectious disease. The antibodies within the company's pipeline are targ...
...ess model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization. Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is signifi...
PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
... and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more info...MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
...livery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog......iation of the PARADIGM trial, a Phase 2 clinical study evaluating MGAWN1, a humanized monoclonal antibody, for the treatment of individuals with suspected centra... advancement for these patients." About MGAWN1 MGAWN1 is a humanized monoclonal antibody that specifically recognizes the envelope (E) protein o...
... affinity and/or titer, for therapeutic applications and high-titer manufacturing cell lines. The company has assembled a portfolio of lead human and humanized antibodies to antigens associated with cancer, neovascular, inflammatory and infectious disease. The antibodies within the company's pipeline are targ...
YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG
...ess model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization. Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is signifi...Access Pharmaceuticals CEO Interviewed on Financial Website
...very and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; and Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which......ess model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization. Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is signifi...
Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
...ted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog whi...PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
... and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more info...Humanized in Biological Definition
...ntibodies for cancer treatment
2.2 Chimeric and humanized antibodies
2.3 FDA approved monoclonal antibodi...ws all these possibilities:
Chimeric and humanized antibodies
One problem in medical applications ...is used, one talks about chimeric antibodies or humanized antibodies .
Another approach involves geneticall...
Humanized in Biological Dictionary
...rapy in Lymphoid Malignancies ... A monoclonal antibody that is being studied in the treatment of some types of ... maytansinoid DM4-conjugated humanized monoclonal antibody huC242 (may-TAN-sih ... Custom antibody , polyclonal antibody and monoclonal antibody service,GenScript ... Monoclo...
Other TagsSPCAEDOther Contentscatheterscatheterscatheterscastscastscastscastsincontinenceincontinenceincontinenceincontinencetracttracttracttracttracttracttracttracturinationurinationurinationchemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrycollectioncollectioncollectioncollectioncollectioncollectioncollectioncollectioncollection
(Date:12/4/2009)... TrekDesk Inventor Showcasing Innovativ... (Vocus) December 4, 2009 -- A valley inven... proven to help individuals lose weight, prevent d...ductivity will be showcasing the product at Saturd...nter Gallery., , , , , TrekDesk has been feature...
(Date:12/4/2009)..., FORT MYERS, Fla., Dec. 4 /PRNewswire-FirstCall...) announced today that Steven C. Jones has been ...at George A. Cardoza has joined the company as Chi...ible for managing all internal financial affairs o...cus on developing strategic initiatives on behalf ...
(Date:12/4/2009)...ASHINGTON, Dec. 4 The f... of the Heinz Family Philanthropies: ,, Credit ... with a significant contribution to the health car...ay Americans living with Phenylketonuria (PKU) con...e way others living with serious chronic condition...
(Date:12/4/2009)...earch finds higher pollution levels, though risks ...y News) -- As corporate and private jets take off ...ir engine exhaust fills the air with small particl...eople living nearby, suggests a new study by Calif...ong been recognized as a problem near major airpor...
(Date:12/4/2009)..., ORLANDO, Fla., Dec. 4 , ,Wha...ida,s largest Medicare, health benef... ( http://humanagames.com ), a senior-friendly ...ee Guidance Center on Tues., Dec. 8... free and open to the public, will featu...
Breaking Medicine News(10 mins):Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:NeoGenomics Announces Executive Appointments 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Smaller Airports May Endanger Health 2Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2[0] Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery[0] NeoGenomics Announces Executive Appointments[0] Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move[0] Smaller Airports May Endanger Health[0] Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee
(Date:12/3/2009)..., UPTON, NY A team of scientists from the U.S. D...boratory, Harvard University, and the Indian Insti...ding how molecules locate the genetic information ...ological processes. The research, published in the...Molecular Biology , confirms that many proteins re...
(Date:12/2/2009)..., , PHILADELPHIA Cigarette smoking and alcohol c...trongly predicts the patient,s future risk of deat... a new study show a similar effect among those who... "Most cancer survivors are counseled to quit smo..., 21 percent continued to smoke even after their c...
(Date:12/2/2009)..., WEST LAFAYETTE, Ind. ╤ A Smoky Mountain f...imate may play a role in how forest understories r...y research. , Despite heavy logging in portions ...n of trillium plants on the secondary forest floor... Jenkins, a Purdue assistant professor of forestry...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Study finds logging effects vary based on a forest's history, climate 2eDiets com 28R 29 to Report Second Quarter Fiscal 2009 Results on Wednesday August 12 2009 53703 1eDiets com 28R 29 to Report Second Quarter Fiscal 2009 Results on Wednesday August 12 2009 53703 2DSM Announces SafeBridge 28R 29 Potent Compound Safety Certification 53701 1DSM Announces SafeBridge 28R 29 Potent Compound Safety Certification 53701 2DSM Announces SafeBridge 28R 29 Potent Compound Safety Certification 53701 3AEterna Zentaris to Announce Second Quarter 2009 Financial and Operating Results on August 11 2009 13378 1| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |